Patient Reports About Fosamax Medication

Posted by Patricia Benson on february 27, 2017

One of the largest pharmaceutical brands in the world, Merck & Co.has been having troubles lately. In the papers today, Merck & suspected of illegal marketing practices with regard to some of its drugs. Yet, the thing that is putting the brand in a bad light is the mounting cases of people suffering adverse effects from the use of its drug Fosamax.

Every year, around 20 million prescriptions are written for Fosamax. Many have known this drug as alendronate, which is its generic form, and as the drug of choice for specific bone diseases like osteoporosis and Paget's disease (osteitis deformans). It makes your bones strong by altering the cycle of bone remodeling particularly and prevent bone resorption.

However, there are mounting reports about the adverse effects that could result from the long term use of the drug. The most frequently reported problems were osteonecrosis of the jaw (ONJ) and a spontaneous type of fracture on the femur. What is more, Merck & Co.seemingly was not able to properly notify its users about the related danger hence the basis of some clients for filing a lawsuit.

It was way back in 2003 when the first Fosamax-related incidence of ONJ was brought to public attention. ONJ, also known to many as Bis-Phossy Jaw, is a disease where a tissue of the jawbone is not receiving much nutrition therefore the tissue dies. Usual manifestation of ONJ is pain upon chewing and most of the time, dentists are the first to diagnose ONJ during a dental checkup.

On a different note, an atypical type of fracture has also been linked to the long-term use of the drug. Large studies have suggested that women who are taking bisphosphonates (a group of drug which includes Fosamax) are likely to suffer a low-impact type of fracture in the femur. Nonetheless, this complication is said to be rare and the benefit of the drug still prevails.

In order to reduce the risks of these adversities, some doctors have opted to prescribe the drug on a shorter course. In most cases, they will tell their patients to temporarily hold Fosamax and other bisphosphonate drugs after 3 years of drug therapy. While the adverse and other side effects of Fosamax are alarming, the benefits of the drug still outweigh the associated risks. Ask your doctor to find out if the drug suits your condition best.